Se Hyun Kim
SK Group (South Korea)(KR)Seoul National University(KR)Kangwon National University(KR)Korea Gas Corporation (South Korea)(KR)Konkuk University(KR)Samsung Medical Center(KR)New Generation University College(ET)Seoul National University Hospital(KR)Seoul National University Bundang Hospital(KR)Daewon Pharm (South Korea)(KR)Hanyang University(KR)Chung-Ang University(KR)Sungkyunkwan University(KR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Breast Cancer Treatment Studies
Most-Cited Works
- → Improving polygenic prediction in ancestrally diverse populations(2022)649 cited
- → Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas(2017)504 cited
- → Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer(2022)267 cited
- → Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer(2014)249 cited
- → Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer(2018)202 cited
- → Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody